Skip to content
sellWeak

Nantahala Capital Management, LLC sold $180 of EVOK

owner at Evoke Pharma Inc. 41 shares at an average of $4.39, traded Jan 28, 2025, filed Jan 30, 2025.

Warning score
12
Value
$180
41 shares
Holdings after
148,153
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $180 at market
    0
  • Share of holdings sold
    Sold 0.0% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001104659-25-007682, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 28, 2025SOpen-market sale
Common Stockindirect: See footnote
-41$4.39$180148,153Jan 30, 2025

Related signals

Other insiders at Evoke Pharma Inc and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
42Moderate
EVOKsell
Evoke Pharma Inc
Roger M. Klein
owner
$96k
9,000 shares
-26%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nantahala Capital Management, LLC sold $180 of EVOK | InsiderTell